FDA Inspection 1205277 — Nabatak Inc
The FDA completed an inspection of Nabatak Inc on June 8, 2023 in Claremore, OK. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Veterinary.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 8, 2023
- Fiscal Year
- 2023
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Claremore, OK (United States)
Additional Details
FSVP